Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

75P - Biosynthesis and characterization of selenium nanoparticles using marine algae Sargassum wightii: Understanding its anticancer activity through ROS-mediated p53 and Akt signaling pathways in A549 cells

Date

15 Oct 2022

Session

Poster display session

Presenters

Chitra Loganathan

Citation

Annals of Oncology (2022) 33 (suppl_8): S1383-S1430. 10.1016/annonc/annonc1095

Authors

C. Loganathan1, P. Sathishkumar2, P. Thayumanavan3

Author affiliations

  • 1 Bioinnov Solutions LLP, Salem/IN
  • 2 SIMATS - Saveetha Institute of Medical and Technical Sciences, Chennai/IN
  • 3 Periyar University, Salem/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 75P

Background

Marine macroalgae Sargassum wightii is abundantly distributed on the southern coasts of Tamil Nadu, India. S. wightii was less explored for its medicinal properties. Although selenium nanoparticles (SeNPs) have been regarded as safer and efficient to enhance various biological functions, the agglomeration of SeNPs hinder its biological applicability. Hence, in the present study, SeNPs was surface functionalized with biologically active compounds present in S. wightii to produce SW-SeNPs which will not only enhance its biological availability but also will synergistically enhance its therapeutic property.

Methods

The biosynthesized SW-SeNPs was characterized using Transmission Electron Microscopy (TEM), Zeta potential analysis, Fourier Transform-Infrared spectroscopy (FT-IR) and X-ray diffraction (XRD). The anticancer effect of SW-SeNPs against A549 cells was determined. Various parameters such as cell viability, reactive oxygen species (ROS) production, DNA fragmentation, cell cycle progression and apoptosis were studied. Also, the level of p53, p-Akt and caspase-3 were determined using flow cytometry.

Results

SW-SeNPs was found to be in the range of 20 - 40 nm size with crystalline nature. The negative zeta potential of SW-SeNPs and FT-IR analysis confirmed the surface binding of bioactive components present in S. wightii in the SW-SeNPs. SW-SeNPs was studied for its anticancer potential against A549 cells. SW-SeNPs affected the A549 cells viability in dose-dependent manner. SW-SeNPs treatment increased the ROS generation and led to DNA fragmentation in A549 cells. Also, the cells were arrested in G2/M phase which ultimately induced apoptosis of the A549 cells through caspase-3 activation. The molecular mechanism of SW-SeNPs-induced A549 cells apoptosis was found to be through overproduced ROS-mediated activation of p53 and AKT signal pathways.

Conclusions

Altogether, the present study demonstrated the anticancer therapeutic effect of SW-SeNPs against lung cancer.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.